title: Ventricular performance in spontaneously hypertensive rats (SHR) with reduced cardiac mass.
abstract: This study was designed to investigate the effect of 4 weeks of captopril treatment on cardiac mass and performance in spontaneously hypertensive rats (SHR). Left (LV) and right (RV) ventricular mass of SHR and normotensive WKY rats was reduced (p less than 0.01). Mean arterial pressure (MAP) and total peripheral resistance index (TPRI) in the treated SHR and WKY were reduced; cardiac (CI) and stroke (SI) indices remained unaltered in SHR but increased in WKY. Ventricular performance (i.e., cardiac pumping ability), assessed by rapid blood infusion, did not differ between untreated SHR and WKY, and between treated and untreated WKY rats. However, the ventricular performance curves for the treated SHR shifted down and to the right from the untreated SHR (p less than 0.01). Moreover, when MAP of treated SHR (with regressed LV mass) was elevated to their pretreatment levels, cardiac performance curves shifted further rightward and downward. In contrast, the performance curves of treated WKY whose MAP was also elevated to the level of untreated WKY were no different from those of untreated WKY. These data demonstrate that captopril treatment (at doses used in this study) reduced MAP in SHR through decreased TPRI while decreasing biventricular mass. Furthermore, the cardiac-pumping ability of previously hypertrophied SHR hearts was reduced, suggesting that certain antihypertensive agents that diminish cardiac mass could produce impaired cardiac function when called upon to increase performance (e.g., when MAP is suddenly raised).
authors.affiliation: Research Division, Alton Ochsner Medical Foundation, New Orleans, LA 70121.
authors.forename: T
authors.initials: T
authors.lastname: Natsume
authors.forename: M B
authors.initials: MB
authors.lastname: Kardon
authors.forename: B L
authors.initials: BL
authors.lastname: Pegram
authors.forename: E D
authors.initials: ED
authors.lastname: Frohlich
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000502:physiology; D002216:Captopril / Q000627:therapeutic use; D006332:Cardiomegaly / Q000503:physiopathology; D004562:Electrocardiography; D006321:Heart / Q000503:physiopathology; D006439:Hemodynamics / Q000502:physiology; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology*; D008297:Male; D009206:Myocardium / Q000473:pathology; D009929:Organ Size; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D016276:Ventricular Function
chemical_list: D002216:Captopril